How big is the Global Sepsis Diagnostics Market?

The Global Sepsis Diagnostics Market size is expected to reach USD 0.74 billion in 2024 and grow at a CAGR of 6.58% to reach USD 1.02 billion by 2029. Read More

What is the current Global Sepsis Diagnostics Market size?

In 2024, the Global Sepsis Diagnostics Market size is expected to reach USD 0.74 billion. Read More

Who are the key players in Global Sepsis Diagnostics Market?

Abbott, Diasorin, Becton, Dickinson, and Company, bioMérieux SA and F. Hoffmann-LA Roche Ltd are the major companies operating in the Global Sepsis Diagnostics Market. Read More

Which is the fastest growing region in Global Sepsis Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Sepsis Diagnostics Market?

In 2024, the North America accounts for the largest market share in Global Sepsis Diagnostics Market. Read More

What years does this Global Sepsis Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Global Sepsis Diagnostics Market size was estimated at USD 694.39 million. The report covers the Global Sepsis Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Sepsis Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Sepsis Diagnostics Market Share

Statistics for the 2023 & 2024 Global Sepsis Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Global Sepsis Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Sepsis Diagnostics Industry

The sepsis diagnostics market is moderately consolidated owing to the presence of a few key players. The market is expected to drive due to the products launched by the key players in the market and the rise in research initiatives on sepsis diagnostics by the key players. Some of the market players are Abbott, Becton, Dickinson, and Company, bioMérieux SA, Bruker Corporation, F. Hoffmann-LA Roche Ltd, and Immunexpress Inc., among others.